A prospective, cohort study analysing response to BNT162b2 Vaccination in pediatric solid organ transplant recipients
Latest Information Update: 01 Aug 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications SARS-CoV-2 acute respiratory disease
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2022 Results (n=37) assessing immunogenicity and safety of a third BNT162b2 vaccine in pediatric solid organ transplant recipients, presented at the 2022 American Transplant Congress.
- 16 Sep 2021 New trial record
- 13 Sep 2021 Results published in the American Journal of Transplantation